Drawing for NASALCARE

USPTO serial 86962363

NASALCARE

Reviewed by CopyMark Law Group

Reg. 5472451Status 702Registered
Filing date
Status date
Registration date
May 22, 2018
Examiner
MAZZELLA, BRANDY BARRETT
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with NASALCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical agents affecting sensory organs; ] [ Pharmaceutical antitussive-cold preparations; ] [ Pharmaceutical preparation for skin care; ] [ Pharmaceutical preparations for the treatment of infectious diseases; ] Pharmaceutical preparations for the treatment of rhinitis, sinusitis; [ Pharmaceutical preparations for treating allergic rhinitis and asthma; ] Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Antibacterial pharmaceuticals; [ Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ethers for pharmaceutical purposes; Homeopathic pharmaceuticals for use in the treatment of common cold, influenza, allergy; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders ]ACTIVEJan 7, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 29, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 13, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 29, 2023PUM2OFFICE ACTION ISSUED POU2—
Aug 29, 2023EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 25, 2023PUM1OFFICE ACTION ISSUED POU1—
Aug 25, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 25, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 12, 2023E815TEAS SECTION 8 & 15 RECEIVED—
May 22, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 22, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 17, 2018TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 17, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Apr 17, 2018OP.DOPPOSITION DISMISSED NO. 999999—
Nov 20, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 19, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 23, 2017GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
May 23, 2017GNSFSUBSEQUENT FINAL EMAILED—
May 23, 2017CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
May 10, 2017DOCKASSIGNED TO EXAMINER—
May 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2017ALIEASSIGNED TO LIE—
Apr 10, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 23, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 23, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 23, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2016DOCKASSIGNED TO EXAMINER—
Apr 8, 2016MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 7, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 6, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance